Market Tracker

01/20 5:16pm ET

Qiagen NV (NASDAQ:QGEN)

27.64
Delayed Data
As of Jan 20
 -0.05 / -0.18%
Today’s Change
19.94
Today|||52-Week Range
28.98
-1.36%
Year-to-Date
Better Buy: Opko Health, Inc. vs. Qiagen
Jan 18 / MotleyFool.com - Paid Partner Content
QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close27.69
Today’s open27.87
Day’s range27.51 - 27.94
Volume1,124,101
Average volume (3 months)968,507
Market cap$6.6B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+184.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.90%
Revenue growth (last year)-4.74%
P/E ratio55.3
Price/Sales5.12
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
PKIPerkinElmer Inc-0.41-0.79%
BIOBio Rad Laboratories...-0.52-0.28%
BRKRBruker Corp-0.27-1.20%
MTDMettler-Toledo Inter...-0.72-0.17%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$1.3B
Annual profit (last year)$127.1M
Net profit margin9.92%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer
Peer Michael Schatz
Senior Vice President-
Global Operations
Douglas Liu
Corporate headquarters
Venlo, Limburg

Forecasts